POSTANESTHETIC NAUSEA, VOMITING, AND RETCHING - EVALUATION OF THE ANTIEMETIC DRUGS DIMENHYDRINATE (DRAMAMINE), CHLORPROMAZINE, AND PENTOBARBITAL SODIUM

被引：86

|

作者：

KNAPP, MR

BEECHER, HK

机构：

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1956年 / 160卷 / 05期

关键词：

D O I：

10.1001/jama.1956.02960400034009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：376 / 385

页数：10

相关论文

共 39 条

[31] Evaluation of the effective drugs for the prevention of nausea and vomiting induced by morphine used for postoperative pain: A quantitative systematic review
Hirayama, T
Ishii, F
Yago, K
Ogata, H
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2001, 121 (02): : 179 - 185
[32] Evaluation of practice patterns for prevention of chemotherapy (CT)-induced nausea and vomiting (CINV) and antiemetic guidelines (GLs) adherence based on real-world prescribing data
Aapro, M. S.
Scotte, F.
Escobar, Y.
Celio, L.
Berman, R. D.
Franceschetti, A.
Bell, D.
Jordan, K.
ANNALS OF ONCOLOGY, 2018, 29
[33] Evaluation of Chemotherapy Induced Nausea and Vomiting for Patients Receiving Post-Transplant Cyclophosphamide for Matched Related and Unrelated Donor Stem Cell Transplant with Ondansetron Plus Rolapitant Antiemetic Prophylaxis.
Andrick, Benjamin
Potter, Allen
Smith, Ashley
Maiers, Tristan
Vadakara, Joseph
Lynch, Joseph
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S391 - S392
[34] Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy
Hesketh, Paul J.
Aapro, Matti
Street, James C.
Carides, Alexandra D.
SUPPORTIVE CARE IN CANCER, 2010, 18 (09) : 1171 - 1177
[35] Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin-cyclophosphamide-based chemotherapy
Warr, David G.
Street, James C.
Carides, Alexandra D.
SUPPORTIVE CARE IN CANCER, 2011, 19 (06) : 807 - 813
[36] Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy
David G. Warr
James C. Street
Alexandra D. Carides
Supportive Care in Cancer, 2011, 19 : 807 - 813
[37] Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy
Paul J. Hesketh
Matti Aapro
James C. Street
Alexandra D. Carides
Supportive Care in Cancer, 2010, 18 : 1171 - 1177
[38] Evaluation of the Role of Preoperative Oral Amisulpride as Part of a Multimodal Antiemetic Prophylaxis Regime on Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy: A Prospective, Double-Blind, Randomized, Placebo-controlled Study
Gupta, Anubha
Gupta, Devendra
Gupta, Pragya
Haldar, Rudrashish
Verma, Ruchi
Mishra, Prabhaker
Srivastava, Shashi
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2024, 36 (04) : 352 - 356
[39] ANALGESIC POTENCY AND SIDE ACTION LIABILITY IN MAN OF HEPTAZONE, WIN 1161-2, 6-METHYL DIHYDROMORPHINE, METOPON, LEVO-ISOMETHADONE AND PENTOBARBITAL SODIUM, AS A FURTHER EFFORT TO REFINE METHODS OF EVALUATION OF ANALGESIC DRUGS
KEATS, AS
BEECHER, HK
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1952, 105 (02): : 109 - 129

← 1 2 3 4 →